These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18985036)

  • 21. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
    Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA
    Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of RET/PTC1 and RET/PTC3 oncoproteins in radiation-induced papillary thyroid carcinomas on amounts of cytoskeletal protein species.
    Zeindl-Eberhart E; Liebmann S; Jungblut PR; Mattow J; Schmid M; Kerler R; Rabes HM
    Amino Acids; 2011 Jul; 41(2):415-25. PubMed ID: 20839015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low dose irradiation of thyroid cells reveals a unique transcriptomic and epigenetic signature in RET/PTC-positive cells.
    Abou-El-Ardat K; Monsieurs P; Anastasov N; Atkinson M; Derradji H; De Meyer T; Bekaert S; Van Criekinge W; Baatout S
    Mutat Res; 2012 Mar; 731(1-2):27-40. PubMed ID: 22027090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute expression of RET/PTC induces isozyme-specific activation and subsequent downregulation of PKCepsilon in PCCL3 thyroid cells.
    Knauf JA; Ouyang B; Croyle M; Kimura E; Fagin JA
    Oncogene; 2003 Oct; 22(44):6830-8. PubMed ID: 14534528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular analysis of structural abnormalities in papillary thyroid carcinoma gene].
    Vasil'ev EV; Rumiantsev PO; Saenko VA; Il'in AA; Poliakova EIu; Nemtsova MV; Zaletaev DV
    Mol Biol (Mosk); 2004; 38(4):642-53. PubMed ID: 15456136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RET oncogene expression of papillary thyroid carcinoma in Korea.
    Chung KW; Chang MC; Noh DY; Oh SK; Choe KJ; Youn YK
    Surg Today; 2004; 34(6):485-92. PubMed ID: 15170542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Genetic factors predisposing to the development of papillary thyroid cancer].
    Puzianowska-Kuźnicka M; Pietrzak M
    Endokrynol Pol; 2005; 56(3):339-45. PubMed ID: 16350729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene.
    Coppée F; Gérard AC; Denef JF; Ledent C; Vassart G; Dumont JE; Parmentier M
    Oncogene; 1996 Oct; 13(7):1471-82. PubMed ID: 8875985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).
    Nakazawa T; Kondo T; Kobayashi Y; Takamura N; Murata S; Kameyama K; Muramatsu A; Ito K; Kobayashi M; Katoh R
    Cancer; 2005 Sep; 104(5):943-51. PubMed ID: 16015630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Frequency of RET/PTC rearrangement and somatic BRAF mutation in papillary thyroid cancer].
    Rumiantsev PO; Zaletaev DV; Vasil'ev EV; Saenko VA; Il'in AA; Rumiantseva UV; Abrosimov AIu; Medvedev VS
    Vopr Onkol; 2006; 52(2):145-9. PubMed ID: 17195637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
    Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
    Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinomas?
    Musholt PB; Imkamp F; von Wasielewski R; Schmid KW; Musholt TJ
    Surgery; 2003 Dec; 134(6):881-9; discussion 889. PubMed ID: 14668719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice.
    Cho JY; Sagartz JE; Capen CC; Mazzaferri EL; Jhiang SM
    Oncogene; 1999 Jun; 18(24):3659-65. PubMed ID: 10380889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation induced thyroid cancer: fundamental and applied aspects.
    Tronko M; Bogdanova T; Voskoboynyk L; Zurnadzhy L; Shpak V; Gulak L
    Exp Oncol; 2010 Sep; 32(3):200-4. PubMed ID: 21403618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas.
    Castellone MD; Guarino V; De Falco V; Carlomagno F; Basolo F; Faviana P; Kruhoffer M; Orntoft T; Russell JP; Rothstein JL; Fusco A; Santoro M; Melillo RM
    Oncogene; 2004 Aug; 23(35):5958-67. PubMed ID: 15184868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RET/PTC and CK19 expression in papillary thyroid carcinoma and its clinicopathologic correlation.
    Shin E; Chung WY; Yang WI; Park CS; Hong SW
    J Korean Med Sci; 2005 Feb; 20(1):98-104. PubMed ID: 15716612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET/PTC3p53-/- mice.
    Powell DJ; Russell JP; Li G; Kuo BA; Fidanza V; Huebner K; Rothstein JL
    Oncogene; 2001 May; 20(25):3235-46. PubMed ID: 11423973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1.
    Moretti S; Menicali E; Nucci N; Voce P; Colella R; Melillo RM; Liotti F; Morelli S; Fallarino F; Macchiarulo A; Santoro M; Avenia N; Puxeddu E
    J Biol Chem; 2017 Feb; 292(5):1785-1797. PubMed ID: 27994058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suitability of animal models for studying radiation-induced thyroid cancer in humans: evidence from nuclear architecture.
    Gandhi M; Nikiforov YE
    Thyroid; 2011 Dec; 21(12):1331-7. PubMed ID: 22136268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene.
    Iavarone C; Acunzo M; Carlomagno F; Catania A; Melillo RM; Carlomagno SM; Santoro M; Chiariello M
    J Biol Chem; 2006 Apr; 281(15):10567-76. PubMed ID: 16484222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.